EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population

Shuichi Tsukamoto, Koji Yamazaki, Ryo Mori, Masakazu Katsura, Hidenori Kouso, Daigo Kawano, Chie Ushijima, Sadanori Takeo

Advances in Lung Cancer · 2014

DOI: 10.4236/alc.2014.31001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Lung Cancer, 2014. Verfasst von Shuichi Tsukamoto und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tsukamoto, S., Yamazaki, K., Mori, R., Katsura, M., Kouso, H., Kawano, D., Ushijima, C., & Takeo, S. (2014). Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population. Advances in Lung Cancer. https://doi.org/10.4236/alc.2014.31001

Vancouver

Tsukamoto S, Yamazaki K, Mori R, Katsura M, Kouso H, Kawano D, et al. Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population. Advances in Lung Cancer. 2014. doi:10.4236/alc.2014.31001

BibTeX
@article{Tsukamoto2014,
  author = {Tsukamoto, Shuichi and Yamazaki, Koji and Mori, Ryo and Katsura, Masakazu and Kouso, Hidenori and Kawano, Daigo and Ushijima, Chie and Takeo, Sadanori},
  title = {Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population},
  journal = {Advances in Lung Cancer},
  year = {2014},
  doi = {10.4236/alc.2014.31001}
}
Kostenlos starten →